| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/19/2004 | WO2001040438A3 Methods and compositions for regulating lymphocyte activity |
| 02/19/2004 | US20040034888 Nucleic acid molecules and other molecules associated with plants and uses thereof for plant improvement |
| 02/19/2004 | US20040034887 Comprises DNA repair enzyme for decreasing free radical damage and increasing crop yield of transgenic plants |
| 02/19/2004 | US20040034885 Methods of using viral replicase polynucleotides and polypeptides |
| 02/19/2004 | US20040034883 Fungl elicitor and process for its preparation |
| 02/19/2004 | US20040034882 Transgenic rodent with mutation in one allele of the corticotropin releasing factor receptor 2 protein for use as animal model in treating and diagnosing anxiety, depression, obesity and diabetes |
| 02/19/2004 | US20040034881 Comprises rodent containing mutation in programmed cell death-1 receptor (PD-1) gene for use as animal model in diagnosis and treatment of dilated cardiomyopathy |
| 02/19/2004 | US20040034878 Using transgenic hypercellular nonhuman organisms as cell proliferating gene therapeutic tools |
| 02/19/2004 | US20040034210 Novel polypeptide-protein p125-77.22 and a polynucleotide encoding the same |
| 02/19/2004 | US20040034208 Comprises nucleotide sequences coding regulatory proteins such as cytokines and interferons for diagnosis and treatment of neurodegenerative, pancreatic and viral diseases |
| 02/19/2004 | US20040034207 Crystal structure of antibiotics bound to the 30S ribosome and its use |
| 02/19/2004 | US20040034201 Enhanced affinity hyaluronan binding peptides |
| 02/19/2004 | US20040034200 Comprises plant oil protein derived from gluten like micellar mass (PMM) for use in animal feeds, pet foods and cosmetics |
| 02/19/2004 | US20040034199 Human pellino polypeptides |
| 02/19/2004 | US20040034198 Mutant p53 (delta126-132) protein and uses thereof |
| 02/19/2004 | US20040034196 Comprises nucleotide sequences coding polypeptide for prevention, diagnosis and treatment of neurodegenerative, behavioral, inflammatory and tumor disorders |
| 02/19/2004 | US20040034195 Multimerized highly functional antifreeze protein |
| 02/19/2004 | US20040034194 Comprises thera.peutic polypeptide for treating and preventing cancer, obesity, diabetes, hyper/hypotension, eating, nervous system and sexual disorders |
| 02/19/2004 | US20040034193 Biosynthetic oncolytic molecules and uses therefor |
| 02/19/2004 | US20040034192 Human proteins having hyprophobic domains and dnas encoding these proteins |
| 02/19/2004 | US20040034191 Novel peptide-conjugated oligomeric compounds |
| 02/19/2004 | US20040034043 Positively-charged peptide nucleic acid analogs with improved properties |
| 02/19/2004 | US20040033978 Antisense oligonucleotides complementary to and that hybridize with RNA, used for gene expression inhibition, prophylaxis and medical diagnosis |
| 02/19/2004 | US20040033971 Polypeptides and nucleic acids encoding same |
| 02/19/2004 | US20040033953 Cry proteins; endotoxins |
| 02/19/2004 | US20040033952 Modified mature insulin variants and composition containing same |
| 02/19/2004 | US20040033951 Modified mature insulin variants and composition containing same |
| 02/19/2004 | US20040033948 Multimeric ligands with enhanced stability |
| 02/19/2004 | US20040033943 Hcn polypeptides and polynucleotides and their use in therapy |
| 02/19/2004 | US20040033942 Transriotion factors |
| 02/19/2004 | US20040033932 Myc targets |
| 02/19/2004 | US20040033607 Comprises nucleotide sequences coding vernalization independence polypeptides (VIP) for contolling the time of flowering in agriculure important crop plants such as tomatoes, corn and lettuce |
| 02/19/2004 | US20040033595 Conditionally replicating vectors for inhibiting viral infections |
| 02/19/2004 | US20040033594 Comprises RNA viral sequences for use in development of diagnostics and genetic vaccines against viral infection |
| 02/19/2004 | US20040033586 Pasteurella and/or actinobacillus mutant coding polypeptide for prevention and treatment of infectious disease; veterinary medicine |
| 02/19/2004 | US20040033585 Preparing tobbaco mosaic viral particles comprising therapeutic polypeptides for treatment of infectious diseases and tumors; immunotherapy; genetic vaccines |
| 02/19/2004 | US20040033584 Using immunoglobulins to diagnose and treat viral, fungal, bacterial and parasitic infections of the reticuloendothelial system; vetrinary medicine; immunotherapy |
| 02/19/2004 | US20040033581 Dual condensation/epimerization domain in non-ribosomal peptide synthetase systems |
| 02/19/2004 | US20040033580 Thermopallium culture for fermenting alkaline favorable, heat resistant pullulanase and/or amylase for use in detergent, paper, pulp and textile industry |
| 02/19/2004 | US20040033569 Using site directed mutagenesis to determine and identify physical landscapes associated with protein structure, function and folding |
| 02/19/2004 | US20040033565 Isolated human G-Protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 02/19/2004 | US20040033564 Method for increasing solubility of target protein using RNA-binding protein as fusion partner |
| 02/19/2004 | US20040033563 Ho-1 suppressor as a diagnostic and prognostic test for dementing diseases |
| 02/19/2004 | US20040033560 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033559 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033558 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/19/2004 | US20040033549 Quorum sensing signaling in bacteria |
| 02/19/2004 | US20040033548 Compositions and methods for regulating bacterial pathogenesis |
| 02/19/2004 | US20040033540 Detecting helminth infection using synthetic larval proteins; immunoassay; parasiticides |
| 02/19/2004 | US20040033534 Using peptide mimetics to prevent binding and gene expression activation by phosphorylated aspartyl regulatory protein; decreasing development of antibiotic resistance in pathogenic bacteria; gene expression inhibition |
| 02/19/2004 | US20040033529 Stabilized composition of troponin for immunoassays and method of preparation of such a stabilized composition |
| 02/19/2004 | US20040033527 Methods of using a three-dimensional model of a Fc epsilon receptor alpha chain |
| 02/19/2004 | US20040033526 Isolated human phospholipase proteins, nucleic acid molecules encoding human phospholipase proteins, and uses thereof |
| 02/19/2004 | US20040033523 Coleopteran-resistant transgenic plants and methods of their production |
| 02/19/2004 | US20040033512 Comprises carbohydrate-assoaiated proteins (CARBAP) for diagnosing, treating and/or preventing cell proliferative, autoimmune/inflammatory, reproductive and nervous system disorders |
| 02/19/2004 | US20040033511 Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines) |
| 02/19/2004 | US20040033504 Novel compounds |
| 02/19/2004 | US20040033500 Comprises nucleotide sequences coding N-methyl-D-aspartate type 3B (NR3B) polypeptides for diagnosing and treating nervous system disorders; antisense agents |
| 02/19/2004 | US20040033497 Comprises nucleotide sequences coding membrane protein associated with lymphocyte development and tolerances for diagnosis and treatment of autoimmune diseases |
| 02/19/2004 | US20040033494 Methods for inducing targeted stimulation of meiotic recombination and kits for performing said methods |
| 02/19/2004 | US20040033493 Comprises membrane and/or enzymatic polypeptide for use in prevention, diagnosis and treatment of cancer, diabetes, cardiomyopathy and atherosclerosis; gene therapy |
| 02/19/2004 | US20040033491 Proteins and nucleic acids encoding same |
| 02/19/2004 | US20040033487 Comprises nucleotide sequences coding associated with glycosylation of viral structural polypeptides; prototype immunogens for treatment and prevention of viral disease; genetic vaccines |
| 02/19/2004 | US20040033236 Recombinant constructs of borrelia burgdorferi |
| 02/19/2004 | US20040033235 Inhibitory of human and non-human retroviral, especially HIV, transmission to uninfected cells. |
| 02/19/2004 | US20040033234 Immunogenic polypetides encoded by mage minigenes and uses thereof |
| 02/19/2004 | US20040033231 First domain comprising a PP14 polypeptide sequence and a second domain comprising a polypeptide sequence of the Fc region of an immunoglobulin protein; treatment of immune system diseases and disorders |
| 02/19/2004 | US20040033230 Breast tumor polypeptides, polynucleotides that encode them, antigen presenting cells that express them, and T cells that are specific for cells that express them. |
| 02/19/2004 | US20040033229 PSMA antibodies and protein multimers |
| 02/19/2004 | US20040033227 Isolated human receptor proteins, nucleic acid molecules encoding human receptor proteins, and uses thereof |
| 02/19/2004 | US20040033221 Method for the treatment of chemonucleolysis |
| 02/19/2004 | US20040033217 Intraperitoneal delivery of genetically engineered mesenchymal stem cells |
| 02/19/2004 | US20040033211 Antigen arrays for treatment of bone disease |
| 02/19/2004 | US20040031696 Descaling stainless steels by immersing in electrolytic cells containing electrolytes solutions comprising sulfuric, hydrofluoric, phosphoric and/or hydrochloric acid, then passing electricity |
| 02/19/2004 | DE10234570A1 New DNA fragment encoding mutant O6-antigen polymerase, useful for identifying Escherichia coli DSM 6601 and for attenuating other O6 serotype strains |
| 02/19/2004 | CA2759572A1 Isolation and identification of t cells |
| 02/19/2004 | CA2534874A1 Method for identifying mhc-presented peptide epitopes for t cells |
| 02/19/2004 | CA2497662A1 Pharmaceutical compositions comprising an hiv envelope protein and cd4 |
| 02/19/2004 | CA2496002A1 Albumin-fused ciliary neurotrophic factor |
| 02/19/2004 | CA2495563A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 02/19/2004 | CA2495456A1 Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof |
| 02/19/2004 | CA2495289A1 Interferon-.alpha. induced gene |
| 02/19/2004 | CA2495222A1 Peptides as solubilizing excipients for transforming growth factor ss proteins |
| 02/19/2004 | CA2495121A1 Nogo receptor antagonists |
| 02/19/2004 | CA2494735A1 Gastric and colon cancer-associated antigens |
| 02/19/2004 | CA2494236A1 Csnk1gs as modifiers of the p21 pathway and methods of use |
| 02/19/2004 | CA2494193A1 Novel immunogenic lipopeptides comprising t-helper and cytotoxic t lymphocyte (ctl) epitopes |
| 02/19/2004 | CA2493977A1 Vaccine composition comprising lipooligosaccharide with reduced phase variability |
| 02/19/2004 | CA2493487A1 Method for isolating an intestinal cholesterol binding protein |
| 02/19/2004 | CA2493297A1 Methods to reprogram splice site selection in pre-messenger rnas |
| 02/19/2004 | CA2493124A1 Vaccine |
| 02/19/2004 | CA2493092A1 Neisserial vaccine compositions comprising a combination of antigens |
| 02/19/2004 | CA2489301A1 Vaccinia virus host range genes to increase the titer of avipoxviruses |
| 02/19/2004 | CA2489030A1 Vaccine composition comprising transferrin binding protein and hsf from gram negative bacteria |
| 02/18/2004 | EP1389306A2 Method for detecting progredient chronic dementia, and corresponding peptides and detection reagents |
| 02/18/2004 | EP1389304A1 Adherent entities and uses therefor |
| 02/18/2004 | EP1389237A2 Novel fibroblast growth factors |
| 02/18/2004 | EP1389236A2 Immunoglobulin superfamily variants expressed in mesenchymal cells and therapeutic uses thereof |
| 02/18/2004 | EP1389235A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 02/18/2004 | EP1389219A2 Dimerized t-cell receptor fragment, its compositions and use |